HOME >> BIOLOGY >> NEWS
Connecticut chemist receives award for cleaner air technology

William C. Pfefferle, of Precision Combustion Inc. in North Haven, Conn., was honored June 17 by the world's largest scientific society for developing technologies that reduce the emission of greenhouse gases. He received one of two 2003 Industrial Innovation Awards at the American Chemical Society's Northeast regional meeting in Saratoga Springs, N.Y.

Nicknamed the "father of catalytic combustion," Pfefferle invented the original catalytic combustor for gas turbine engines in the early 1970s. Gas turbines used to provide thrust for jet aircraft and generate electricity work by mixing fuel with compressed and heated air, which then burns and generates energy to turn the turbines. Unfortunately, nitrogen oxide gases, which contribute to global warming, are emitted during this process. Pfefferle has developed a process that uses a catalyst a substance used to speed up a chemical reaction to allow combustion without the significant formation of nitrogen oxides and carbon monoxide.

Pfefferle, who cofounded Precision Combustion in 1986, has dedicated his career to developing clean and efficient technologies for combustion engines. He has also invented the Microlith(r) catalytic reactor for automobiles and fuel processing and the RCL™ catalytic combustor for ground-power gas turbine machines.

Pfefferle received a bachelor's degree in chemical engineering from Drexel University and a doctorate in physical chemistry from the University of Pennsylvania. He holds 90 U.S. patents and has several pending.

The American Chemical Society's Industrial Innovation Awards recognize individuals and teams whose discoveries and inventions contribute to the commercial success of their companies and enhance our quality of life.


'"/>

Contact: Sharon Worthy
s_worthy@acs.org
202-872-4371
American Chemical Society
23-Jun-2003


Page: 1

Related biology news :

1. Nerac again named one of Connecticuts fastest growing technology companies
2. Michigan, Connecticut and Illinois chemists receive award for drug to combat antibiotic resistance
3. NOAA fisheries, Connecticut, New York Sea Grant Programs announce research grants: $3.5 million in sound research to address lobster die-offs
4. UT Southwestern biochemist honored with NIH Directors Pioneer Award
5. NJIT chemist speaks Aug. 25 about compound derived from pine tree
6. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
7. U of T research answers key question in biochemistry
8. Carnegie Mellon University hosts ACS-PRF summer school on green chemistry
9. Rutgers chemist uses NMR to elucidate protein-DNA interaction
10. New multidisciplinary research tops chemists meeting Aug. 22-26
11. Wisconsin chemists find a new chink in TBs armor

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Connecticut chemist receives award for cleaner air technology

(Date:4/23/2014)... term for novels and films which focus on the consequences ... how these fictions serve as a mental laboratory that allows ... imagine other living conditions. , "Global warming is much ... is also a cultural phenomenon in which meaning is being ... see. And there are so many of them now that ...
(Date:4/23/2014)... biomedical engineer at the University of Houston (UH) is ... transfusions safer. His work is supported by a $1.8 ... , Blood transfusions save millions of lives every ... Without them, for instance, routine surgeries would become life ... strong evidence that transfusions of red blood cells stored ...
(Date:4/22/2014)... to behave at the dinner tablecut up their food and ... Eating Behaviors , found that when 6-10 year old children ... such as drumsticks, whole apples, or corn on the cob ... cut. "They were twice as likely to disobey adults ... Professor and Director of the Cornell Food and Brand Lab. ...
Breaking Biology News(10 mins):Fiction prepares us for a world changed by global warming 2Fiction prepares us for a world changed by global warming 3UH biomedical engineer works to make blood transfusions safer 2UH biomedical engineer works to make blood transfusions safer 3Biting vs. chewing 2
(Date:1/14/2014)... Texas , Jan. 14, 2014 The ... and research medicinal plants and therapeutic derivatives thereof ... health professionals, and researchers about the challenges of ... http://photos.prnewswire.com/prnh/20100430/DC95601LOGO ) The Society ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility ... of Product Strategy. In this role, Michelle will work with ... guide in the development of iLab products. Her main goal ... benefit to the scientific community by offering the most advanced, ...
(Date:1/14/2014)... Mass. , Jan. 14, 2014  RXi Pharmaceuticals ... discovering, developing and commercializing innovative therapies addressing major ... that it received the Notice of Allowance from ... its unique self-delivering RNAi compounds (sd-rxRNA®), for the ...
(Date:1/14/2014)... Ontario , Jan. 14, 2014   Kinaxis ®, provider ... SCM ) and sales and operations planning ( S&OP ) ... Biomanufacturing Summit , which will be held at the ... the conference, join Kinaxis customer Elisabeth Kaszas , Director ...
Breaking Biology Technology:World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
Cached News: